Tech Company Financing Transactions
AlveoGene Funding Round
Harrington Discovery Institute at University Hospitals, Old College Capital and Oxford Science Enterprises participated in a Seed funding round for AlveoGene. The round was announced on 9/14/2023.
Transaction Overview
Company Name
Announced On
9/14/2023
Transaction Type
Amount
Unknown
Round
Seed
Investors
Proceeds Purpose
Created and funded by Oxford Science Enterprises, Harrington Discovery Institute and Old College Capital in partnership with six leading scientists from the world-renowned UK Respiratory Gene Therapy Consortium (GTC), AlveoGene is a new gene therapy company that initially aims to leverage proprietary lentiviral gene therapy platform designed and developed by GTC specifically for inhaled delivery. First target indication is alpha-1 antitrypsin deficiency disease (AATD), a degenerative condition that can lead to early onset emphysema
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
46 Woodstock Rd
Oxford, OX2 6HT
UK
Oxford, OX2 6HT
UK
Phone
Undisclosed
Website
Email Address
Overview
AlveoGene is an innovative company focused on transforming rare respiratory disease outcomes using inhaled gene therapy. AlveoGene has been created by OSE, Harrington and OCC in partnership with six leading scientists from the world-renowned UK Respiratory Gene Therapy Consortium (GTC). The GTC was founded in 2001 to catalyse the application of pioneering research to gene therapy development and manufacturing related to cystic fibrosis and other respiratory diseases, and originated at Imperial College London and the Universities of Oxford and Edinburgh.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Hipkiss
Co-Founder
Eric Alton
Browse more venture capital transactions:
Prev: 9/14/2023: Glass Health venture capital transaction
Next: 9/14/2023: Layer N venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs